Suppressive effect of oestradiol on chemical hepatocarcinogenesis in rats. Issue 1 (1st January 1998)

• Record Type: Journal Article
• Authors: Shimizu, I; Yasuda, M; Mizobuchi, Y; Ma, Y-R; Liu, F; Shiba, M; Horie, T; Ito, S
• Is Part Of: Gut. Volume 42:Issue 1(1998)
• Page Start: 112
• Page End: 119
• Publication Date: 1998-01-01
• Subjects: hormone receptor -- testosterone -- diethylnitrosamine -- glutathione-S-transferase placental form -- antioxidant; Gastroenterology -- Periodicals; 616.33
• DOI: 10.1136/gut.42.1.112
• Languages: English
• ISSNs: 0017-5749

Abstract

Abstract : Aims —To examine the effects of oestradiol and testosterone on the early carcinogenic changes expressed in rat liver from the diethylnitrosamine (DEN), 2-acetylaminofluorene (AAF), partial hepatectomy (PH) model of hepatocarcinogenesis. Methods —Preneoplastic liver lesions were evaluated using immunohistochemical analysis of glutathione-S-transferase placental form (GST-P) expression; oestrogen and androgen receptor levels were measured by radioimmunoassay. Results—Oestradiol administration to non-castrated DEN-AAF-PH treated males resulted in a decrease in the area of GST-P positive foci, while testosterone increased the serum oestradiol level and reduced the area. In males, castration alone and castration with oestradiol replacement significantly reduced the GST-P positive area, and increased the hepatic oestrogen receptor level. In DEN-AAF-PH treated females, castration with testosterone replacement was associated with a significant increase in the GST-P positive area and the hepatic androgen receptor level. Conclusion —These findings suggest that exogenous and endogenous oestradiol can suppress chemical hepatocarcinogenesis. It appears that oestrogen receptors may be involved in the inhibition of malignant transformation of preneoplastic liver cells, while androgens and androgen receptors are involved in hepatocarcinogenesis.